These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Molimard M; Diquet B; Benedetti MS Fundam Clin Pharmacol; 2004 Aug; 18(4):399-411. PubMed ID: 15312146 [TBL] [Abstract][Full Text] [Related]
3. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine. Chosidow O; Dubruc C; Danjou P; Fuseau E; Espagne E; Bianchetti G; Thenot JP; Herson S; Rosenzweig P; Revuz J Eur J Clin Pharmacol; 1996; 50(4):327-33. PubMed ID: 8803528 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model. Deschamps C; Dubruc C; Mentre F; Rosenzweig P Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025 [TBL] [Abstract][Full Text] [Related]
5. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation. Simons FE Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699 [TBL] [Abstract][Full Text] [Related]
7. Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteers. Chaufour S; Le Coz F; Denolle T; Dubruc C; Cimarosti I; Deschamps C; Ulliac N; Delhotal-Landes B; Rosenzweig P Int J Clin Pharmacol Ther; 1998 May; 36(5):286-91. PubMed ID: 9629994 [TBL] [Abstract][Full Text] [Related]
8. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects. Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of histamine-induced skin wheal and flare after 5 days of mizolastine. Pinquier JL; Caplain H; Cabanis MJ; Dubruc C; Stalla-Bourdillon A; Rosenzweig P J Clin Pharmacol; 1996 Jan; 36(1):72-8. PubMed ID: 8932546 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine. Rosenzweig P; Thebault JJ; Caplain H; Dubruc C; Bianchetti G; Fuseau E; Morselli PL Ann Allergy; 1992 Aug; 69(2):135-9. PubMed ID: 1354949 [TBL] [Abstract][Full Text] [Related]
11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations. Schran HF; Petryk L; Chang CT; O'Connor R; Gelbert MB J Clin Pharmacol; 1996 Oct; 36(10):911-22. PubMed ID: 8930778 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression. Fleishaker JC Clin Pharmacokinet; 2000 Dec; 39(6):413-27. PubMed ID: 11192474 [TBL] [Abstract][Full Text] [Related]
15. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h. Purohit A; Mélac M; Pauli G; Frossard N Br J Clin Pharmacol; 2002 Mar; 53(3):250-4. PubMed ID: 11874388 [TBL] [Abstract][Full Text] [Related]
16. Single dose pharmacokinetics of cetirizine in young and elderly volunteers. Lefebvre RA; Rosseel MT; Bernheim J Int J Clin Pharmacol Res; 1988; 8(6):463-70. PubMed ID: 2908109 [TBL] [Abstract][Full Text] [Related]